Back

Global Learning Collaborative

  • Glucagon-Like Peptide-1 Receptor Agonists
  • Optic Neuritis
  • Optic Neuropathy, Ischemic

Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow s Treatments

This program addresses critical practice gaps in the evaluation and management of non-arteritic anterior ischemic optic neuropathy (NAION). Faculty will review acute ischemic pathophysiology, diagnostic variability, and structured approaches to improve diagnostic accuracy and readiness for clinical trials. Through case-based discussions, participants will learn how to identify key mimickers (eg, optic neuritis, AION) through targeted testing, apply evidence-based evaluation pathways, improve documentation practices, and recognize referral scenarios. The program will also highlight the impact of systemic risk factors, including GLP-1 receptor agonists, and provide the latest data on investigational agents like cenegermin and privosegtor. Designed for neuro-ophthalmologists, ophthalmologists, and neurologists, this activity supports enhanced diagnostic precision, informed patient counseling, and preparation for emerging NAION therapies.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Case-based learning
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Apr 30, 2026
  • Last day to claim credit
    May 1, 2027 7 months left